Xopenex and Naloxone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xopenex (levalbuterol hydrochloride) and Naloxone (naloxone hydrochloride). Common drug interactions include hypokinesia among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Xopenex and Naloxone. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Xopenex?

Xopenex has active ingredients of levalbuterol hydrochloride. It is often used in asthma. eHealthMe is studying from 13,816 Xopenex users. Check the latest studies of Xopenex.

What is Naloxone?

Naloxone has active ingredients of naloxone hydrochloride. eHealthMe is studying from 6,425 Naloxone users. Check the latest studies of Naloxone.

On Jul, 06, 2026

24 people who take Xopenex and Naloxone together, and have interactions are studied.

What are the common drug interactions of Xopenex and Naloxone, by gender? *:

female:

Hypokinesia (decreased bodily movement)
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Impaired work ability
Pain
Ascites (accumulation of fluid in the abdominal cavity)
Fibromyalgia (a long-term condition which causes pain all over the body)
Metastases to liver (cancer spreads to liver)
Metastases to peritoneum (cancer spreads to peritoneum)
Ovarian cancer metastatic (cancer of ovary spreads to other organ or parts)
Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)

male:

Arthralgia (joint pain)
Back pain
Productive cough
Sepsis (a severe blood infection that can lead to organ failure and death)
Dyspnoea exertional (breathlessness or shortness of breath)
Gastric disorder (disease of stomach)
Head injury
Malignant neoplasm progression (cancer tumour came back)
Sleep disorder
Chronic kidney disease

What are the common drug interactions of Xopenex and Naloxone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Malignant neoplasm progression (cancer tumour came back)
Sepsis (a severe blood infection that can lead to organ failure and death)

20-29:

n/a

30-39:

n/a

40-49:

Fibromyalgia (a long-term condition which causes pain all over the body)
Hypokinesia (decreased bodily movement)
Pain
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Impaired work ability

50-59:

Chronic kidney disease
Renal failure (kidney dysfunction)

60+:

Ascites (accumulation of fluid in the abdominal cavity)
Metastases to liver (cancer spreads to liver)
Generalised oedema (swelling all over the body)
Headache (pain in head)
Hepatic steatosis (fatty liver disease)
Hypervolaemia (abnormally increased volume of blood)
Metastases to lymph nodes (cancer spreads to lymph node)
Metastatic lymphoma (spreadable cancer tumour of lymph node)
Pancreatitis (inflammation of pancreas)
Pancreatitis acute (sudden inflammation of pancreas)

What are the existing conditions these people have? *

Stress And Anxiety: 8 people, 33.33%
Wheezing (a high-pitched whistling sound made while you breath): 7 people, 29.17%
Muscle Aches (muscle pain): 7 people, 29.17%
Fibromyalgia (a long-term condition which causes pain all over the body): 7 people, 29.17%
Primary Immunodeficiency Syndrome: 6 people, 25.00%
Immunodeficiency Common Variable: 6 people, 25.00%
Pain: 2 people, 8.33%
Nausea (feeling of having an urge to vomit): 2 people, 8.33%
Multiple Allergies (allergy to multiple agents): 2 people, 8.33%
Insomnia (sleeplessness): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Xopenex and Naloxone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously